Comment on: Serotonin syndrome due to co-administration of linezolid and venlafaxine [1]

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 4, 2004, Pages 844-845

  Gillman, P Ken ^a  

^a Pioneer Valley Private Hospital   (Australia)

Author keywords

Interactions; Oxazolidinones; Selective serotonin reuptake inhibitors; SSRIs

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BROMPHENIRAMINE; CHLORPHENIRAMINE; DULOXETINE; LINEZOLID; MILNACIPRAN; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NARCOTIC ANALGESIC AGENT; PETHIDINE; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE; TRAMADOL; TYRAMINE; VENLAFAXINE;

AUTONOMIC DYSFUNCTION; CLONUS; CONFUSION; DIAPHORESIS; DRUG CROSS REACTIVITY; DRUG FATALITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EUPHORIA; FEVER; HUMAN; HYPERACTIVITY; HYPERREFLEXIA; LETTER; MEDICAL PRACTICE; MUSCLE HYPERTONIA; MUSCLE RIGIDITY; MYDRIASIS; MYOCLONUS; NEUROMUSCULAR DISEASE; PYRAMIDAL SIGN; RESTLESSNESS; SEROTONIN SYNDROME; SIDE EFFECT; TACHYCARDIA; TACHYPNEA; TREMOR;

ACETAMIDES; ANTI-BACTERIAL AGENTS; CYCLOHEXANOLS; DRUG SYNERGISM; HUMANS; OXAZOLIDINONES; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 6344243546     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh404     Document Type: Letter

References (12)

1. Jones, S. L., Athan, E. & O'Brien, D. (2004). Serotonin syndrome due to co-administration of linezolid and venlafaxine. Journal of Antimicrobial Chemotherapy 54, 289-90.
2. Gillman, P. K. (2003). Linezolid and serotonin toxicity. Clinical Infectious Diseases 37, 1274-5.
3. Gillman, P. K. (1998). Serotonin syndrome: history and risk. Fundamental and Clinical Pharmacology 12, 482-91.
4. Whyte, I. M., Dawson, A. H. & Buckley, N. A. (2003). Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. Quarterly Journal of Medicine 96, 369-74.
5. Isbister, G., Hackett, L., Dawson, A. et al. (2003). Moclobemide poisoning: toxicokinetics and occurrence of serotonin toxicity. British Journal of Clinical Pharmacology 56, 441-50.
6. Dunkley, E., Isbister, G., Sibbritt, D. et al. (2003). The Hunter Serotonin Toxicity Criteria: a simple and accurate diagnostic decision rules for serotonin toxicity. Quarterly Journal of Medicine 96, 635-42.
7. Gillman, P. K. & Whyte, I. M. (2004). Serotonin syndrome. In Adverse Syndromes and Psychiatric Drugs (Haddad, P., Dursun, S. & Deakin, B., Eds). Oxford University Press, Oxford, UK.
8. Whyte, I. M. (2004). Serotonin toxicity (syndrome). In Medical Toxicology, 3rd edn (Dart, R. C., Ed.), pp. 103-6. Lippincott Williams & Wilkins, Baltimore, MD, USA.
9. Gillman, P. K. (2004) Serotonin toxicity (serotonin syndrome): a current analysis. [Online.] www.psychotropical.com/SerotoninToxicity.-doc, Psychopharmacology Update Notes (July 2004, date last accessed).
10. Gillman, P. K. & Hodgens, S. (1998). Serotonin syndrome following SSRI mono-therapy. Human Psychopharmacology 13, 525-6.
11. Antal, E. J., Hendershot, P. E., Batts, D. H. et al. (2001). Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramine. Journal of Clinical Pharmacology 41, 552-62.
12. Perry, C. M. & Jarvis, B. (2001). Linezolid: a review of its use in the management of serious Gram-positive infections. Drugs 61, 525-51.